Therapeutic and diagnostic functions of one antibody for pancreatic cancer

by Osaka UniversityFig.1: DKK1–CKAP4 signaling and application of the anti-CKAP4 antibody. DKK1 and CKAP4 are overexpressed in cancer cells and the PI3 kinase–AKT pathway is activated, promoting

Updated on: May 20,2024 8

Therapeutic and diagnostic functions of one antibody for pancreatic cancer

by Osaka UniversityFig.1: DKK1–CKAP4 signaling and application of the anti-CKAP4 antibody. DKK1 and CKAP4 are overexpressed in cancer cells and the PI3 kinase–AKT pathway is activated, promoting

Updated on:May 20,2024 8

Study reveals pathways for aggressive prostate cancer subtype

by Vanderbilt University Medical CenterScRNAseq of ICC/IDC-enriched and benign-enriched prostate. a Schematic of scRNAseq protocol of ICC/IDC-enriched and benign-enriched prostate. b Representati

Updated on: February 23,2024 14

Study reveals pathways for aggressive prostate cancer subtype

by Vanderbilt University Medical CenterScRNAseq of ICC/IDC-enriched and benign-enriched prostate. a Schematic of scRNAseq protocol of ICC/IDC-enriched and benign-enriched prostate. b Representati

Updated on:February 23,2024 14

The sugar-attaching enzyme that defines colon cancer

by American Society for Biochemistry and Molecular BiologyThe enzyme GalNAc-T6 is selectively up-regulated in colon adenocarcinomas, and its expression is associated with a cancer-like growth pat

Updated on: April 14,2024 15

The sugar-attaching enzyme that defines colon cancer

by American Society for Biochemistry and Molecular BiologyThe enzyme GalNAc-T6 is selectively up-regulated in colon adenocarcinomas, and its expression is associated with a cancer-like growth pat

Updated on:April 14,2024 15

Researchers solving treatment resistance in most common breast cancer

by University of Pittsburgh Schools of the Health SciencesMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainAt Magee-Womens Research Institute (MWRI

Updated on: March 01,2024 15

Researchers solving treatment resistance in most common breast cancer

by University of Pittsburgh Schools of the Health SciencesMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainAt Magee-Womens Research Institute (MWRI

Updated on:March 01,2024 15

Cancer patients facing housing instability show greater risk of mortality

byUniversity of California - San DiegoThe study was led by Matthew P. Banegas, PhD, an associate professor at UC San Diego School of Medicine and co-director of the Center for Health Equity Educ

Updated on: January 02,2024 9

Cancer patients facing housing instability show greater risk of mortality

byUniversity of California - San DiegoThe study was led by Matthew P. Banegas, PhD, an associate professor at UC San Diego School of Medicine and co-director of the Center for Health Equity Educ

Updated on:January 02,2024 9

Study brings insight to kidney cancer with gene mutation

by Anna Megdell,University of MichiganCredit: Pixabay/CC0 Public DomainA new study from clinicians and researchers at the University of Michigan Rogel Cancer Center, U-M Department of Pathology

Updated on: January 30,2024 11

Study brings insight to kidney cancer with gene mutation

by Anna Megdell,University of MichiganCredit: Pixabay/CC0 Public DomainA new study from clinicians and researchers at the University of Michigan Rogel Cancer Center, U-M Department of Pathology

Updated on:January 30,2024 11

Researchers discover molecule that promotes production of cancer cells in triple-negative breast cancer

byHiroshima UniversityHiroshima University researchers found that AIbZIP is highly upregulated in triple negative breast cancer (TNBC). AIbZIP induces hyper proliferation of TNBC cells by promot

Updated on: March 30,2024 0

Researchers discover molecule that promotes production of cancer cells in triple-negative breast cancer

byHiroshima UniversityHiroshima University researchers found that AIbZIP is highly upregulated in triple negative breast cancer (TNBC). AIbZIP induces hyper proliferation of TNBC cells by promot

Updated on:March 30,2024 0

Young age associated with worse prognosis in specific breast cancer subtype

by Johns Hopkins University School of MedicineResearcher in lab. Credit: Johns Hopkins Kimmel Cancer CenterResearchers at Johns Hopkins Kimmel Cancer Center are rapidly advancing the understandin

Updated on: April 22,2024 12

Young age associated with worse prognosis in specific breast cancer subtype

by Johns Hopkins University School of MedicineResearcher in lab. Credit: Johns Hopkins Kimmel Cancer CenterResearchers at Johns Hopkins Kimmel Cancer Center are rapidly advancing the understandin

Updated on:April 22,2024 12

New method to determine before surgery which prostate tumors pose a lethal threat

by Cold Spring Harbor LaboratoryScreen shot from a new genome-viewing program (single cell genomic viewer, or SCGV) that displays results of CSHL's innovative method for analyzing diagnostic

Updated on: April 22,2024 10

New method to determine before surgery which prostate tumors pose a lethal threat

by Cold Spring Harbor LaboratoryScreen shot from a new genome-viewing program (single cell genomic viewer, or SCGV) that displays results of CSHL's innovative method for analyzing diagnostic

Updated on:April 22,2024 10

Neuronal molecule makes prostate cancer more aggressive

byThomas Jefferson UniversityCredit: Unsplash/CC0 Public DomainProstate cancer is the second most common cancer and the second leading cause of cancer death among American men. Now, researchers

Updated on: January 04,2024 8

Neuronal molecule makes prostate cancer more aggressive

byThomas Jefferson UniversityCredit: Unsplash/CC0 Public DomainProstate cancer is the second most common cancer and the second leading cause of cancer death among American men. Now, researchers

Updated on:January 04,2024 8

Osimertinib with savolitinib demonstrates stronger efficacy than osimertinib alone in some patients

by International Association for the Study of Lung CancerCredit: Unsplash/CC0 Public DomainThe combination of osimertinib and savolitinib showed clinically meaningful improvement in objective response

Updated on: September 27,2024 0

Osimertinib with savolitinib demonstrates stronger efficacy than osimertinib alone in some patients

by International Association for the Study of Lung CancerCredit: Unsplash/CC0 Public DomainThe combination of osimertinib and savolitinib showed clinically meaningful improvement in objective response

Updated on:September 27,2024 0

Study reveals significant global disparities in cancer care across different countries

byWileyCredit: Pixabay/CC0 Public DomainA recent analysis reveals striking disparities in the cost and availability of cancer drugs across different regions of the globe, with significant gaps b

Updated on: November 30,2024 0

Study reveals significant global disparities in cancer care across different countries

byWileyCredit: Pixabay/CC0 Public DomainA recent analysis reveals striking disparities in the cost and availability of cancer drugs across different regions of the globe, with significant gaps b

Updated on:November 30,2024 0